In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ReGen Biologics Inc.

www.regenbio.com

Latest From ReGen Biologics Inc.

Innovation Is Alive And Well In Sports Medicine

The sports medicine market comprises a number of product segments, many of which span several different orthopedics specialties.This space is expected to experience strong growth going forward as companies develop innovative ways, including some lower-cost approaches, to treat the joint and soft-tissue injuries commonly suffered by athletes and other sports enthusiasts.

Medical Device

Washington Roundup, March 2012

The latest medical device regulatory and reimbursement news from Elsevier Business Intelligence’s “The Gray Sheet.” This month we cover FDA’s proposed comprehensive postmarket surveillance strategy, as well as updates on proposed 510(k) reforms and device user fees.

Medical Device United States

What Will CMS Do With Avastin In Breast Cancer?

With FDA’s decision to pull the indication for Avastin in breast cancer, CMS is now waiting and watching for residual use patterns.

BioPharmaceutical Medicare

Cartilage Repair: Opportunities In Motion-Preserving Orthopedics

Start-ups and investors are looking to address the large and growing gap between palliative treatment and major joint surgery for patients with cartilage damage in the knee, toes and hands - although the FDA is putting up more roadblocks than ever before. In this issue we profile Articulinx, Carticept Medical and Orthox.
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Aros Corp.
  • Apache Medical Systems Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • ReGen Biologics Inc.
  • Senior Management
  • Gerald E Bisbee, Jr., PhD, Chmn., Pres. & CEO
    Brion D Umidi, SVP, CFO
    Thomas E Ichim, PhD, CSO & Dir., Research
    Jeff Chandler, SVP, Sales & Mtg.
  • Contact Info
  • ReGen Biologics Inc.
    Phone: (201) 651-5140
    411 Hackensack Ave.
    Hackensack, NJ 07601
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register